James Panek
Direttore/Membro del Consiglio presso SUTRO BIOPHARMA, INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di James Panek
Società | Posizione | Inizio | Fine |
---|---|---|---|
SUTRO BIOPHARMA, INC. | Direttore/Membro del Consiglio | 07/01/2020 | - |
Independent Dir/Board Member | 07/01/2020 | - | |
Cho Plus, Inc. | Direttore operativo | - | - |
Storia della carriera di James Panek
Precedenti posizioni note di James Panek
Società | Posizione | Inizio | Fine |
---|---|---|---|
DIADEXUS, INC. | Direttore/Membro del Consiglio | 01/01/2007 | 01/01/2011 |
Amministratore Delegato | 01/01/2010 | 01/01/2011 | |
Direttore Finanziario/CFO | 01/01/2010 | 01/01/2011 | |
Presidente | 01/01/2010 | 01/01/2011 | |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Direttore/Membro del Consiglio | 10/08/2010 | 01/11/2010 |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Comptroller/Controller/Auditor | 01/01/2007 | 01/01/2010 |
Direttore/Membro del Consiglio | 01/01/2007 | 01/01/2010 | |
Direttore Finanziario/CFO | 01/01/2007 | 01/01/2010 | |
Corporate Officer/Principal | 01/02/2002 | 01/01/2006 | |
Presidente | 01/01/2007 | 01/01/2010 | |
CELLTRION, INC. | Amministratore Delegato | 01/01/2002 | 01/01/2006 |
Presidente | 01/01/2002 | 01/01/2006 | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1982 | 01/01/2001 |
Formazione di James Panek
University of Michigan | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Corea del Sud | 2 |
Posizioni
Director/Board Member | 4 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
SUTRO BIOPHARMA, INC. | Health Technology |
CELLTRION, INC. | Health Technology |
Aziende private | 5 |
---|---|
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
Diadexus, Inc.
Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Cho Plus, Inc. |
- Borsa valori
- Insiders
- James Panek
- Esperienza